SCHEMBL4452257

SCHEMBL4452257

[O]C(=O)OCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL154645 0.77
SCHEMBL24073187 0.74 ALDH1A1 (0.37)
SCHEMBL8813456 0.73
SCHEMBL576905 0.71
SCHEMBL12158575 0.71 MGAM (0.53)
Ethylene SCHEMBL21749883 0.71 ALDH1A1 (0.42)
SCHEMBL1052875 0.71
SCHEMBL11426169 0.69 ALDH1A1 (0.35)
SCHEMBL1766405 0.69
Bicarbonate SCHEMBL16592510 0.69 SMN1; SMN2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629494-B2 Process for producing cyclopropylphenol derivative MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-08 US disclosed
US-20090054681-A1 Production Process of cyclopropylphenol derivatives SANKYO AGRO COMPANY, LIMITED (JP) 2009-02-26 US disclosed
EP-1880987-A1 PROCESS FOR PRODUCING CYCLOPROPYLPHENOL DERIVATIVE Sankyo Agro Company, Limited (JP) 2008-01-23 EP disclosed
CN-1125817-C Quinazoline derivatives as VEGF inhibitors ZENECA LTD (GB) 2003-10-29 CN disclosed
CN-1211239-A Quinazoline derivatives as VEGF inhibitors ZENECA LTD (GB) 1999-03-17 CN disclosed
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed